临床试验和家庭医疗解决方案提供商H Clinical宣布获得股权融资-动脉网

H Clinical Announces Majority Investment from Emerald Square Ventures

CISION 等信源发布 2026-09-16 21:05



可切换为仅中文







Investment supports expansion of in-country clinical research staffing, patient recruitment and hybrid delivery capacity for sponsors and CROs across Latin America.

该投资支持扩大拉丁美洲各国境内的临床研究人员配置、患者招募以及为申办方和合同研究组织（CRO）提供混合式交付能力。

ST. PETERSBURG, Fla.

佛罗里达州圣彼得堡

，

Sept. 16, 2026

2026年9月16日

/PRNewswire/ --

/美通社/ --

H Clinical

H 临床

today announced a partnership with

今日宣布与

Emerald Square Ventures

翡翠广场创投

(ESV), which made a majority investment in H Clinical, Inc.

（ESV），其对 H Clinical, Inc. 进行了多数股权投资。

Mitchell Parrish

米切尔·帕里什

continues as Chief Executive Officer.

继续担任首席执行官。

'What we have spent six years building is difficult to build and impossible to shortcut — people in the communities where trials run, their relationships with sites, and the infrastructure behind them,' said Mitchell Parrish, CEO of H Clinical. 'This investment puts more of it in front of clients.'

“我们耗时六年打造的体系难以复制，更无法走捷径——包括开展试验的社区、这些社区与研究中心之间的关系，以及支撑这一切的基础设施。”H Clinical 首席执行官米切尔·帕里什表示，“这项投资将更多这样的资源呈现在客户面前。”

继续阅读

H Clinical receives majority investment from Emerald Square Ventures to expand teams and services across Latin America.

H Clinical 获得 Emerald Square Ventures 的多数股权投资，以扩大其在拉丁美洲的团队和服务。

Post this

发布此内容

H Clinical has also added two executives to its leadership team.

H Clinical 还为其领导团队新增了两名高管。

Ben Joers

本·乔尔斯

joins as Chief Financial Officer, leading financial strategy, planning and infrastructure.

出任首席财务官，负责领导财务战略、规划及基础设施建设。

Eddie Hannush

埃迪·汉努什

joins as Chief Commercial Officer, leading commercial strategy and the growth of client partnerships and service offerings.

出任首席商务官，负责领导商业战略，推动客户合作伙伴关系及服务业务的增长。

'We work with sponsors, CROs, and sites in whatever combination a study needs,' said Eddie Hannush, Chief Commercial Officer. 'When staffing, recruitment, home visits and logistics run off one local platform, the study moves faster and the patient has a better experience.'

首席商务官Eddie Hannush表示：“我们根据研究需求，与申办方、合同研究组织（CRO）和研究站点以任意组合方式开展合作。当人员配置、受试者招募、家庭访视和物流均由同一个本地平台统筹时，研究推进速度更快，患者的体验也更佳。”

The investment supports the services clients are asking H Clinical to expand, and the in-country teams behind them:

这笔投资支持客户希望H Clinical扩展的服务，以及支撑这些服务的本土团队：

Site solutions and project staffing.

现场解决方案与项目人员配置。

Clinical research coordinators, nurses and study personnel sourced, trained and managed by H Clinical for sites region-wide — on site, remote or hybrid.

H Clinical 为区域内的研究中心提供临床协调员、护士和研究人员的招聘、培训与管理服务，支持现场、远程或混合模式。

Community-based patient recruitment.

基于社区的患者招募。

Patient engagement teams working through referring physicians, health centers, patient associations and community events.

患者参与团队通过转诊医生、健康中心、患者协会和社区活动开展工作。

In-home and hybrid trial support.

居家与混合式试验支持。

Study visits in patients' homes, with sample collection, shipments and in-country regulatory work.

在患者家中进行的研究访视，包括样本采集、运输以及国内的监管事务工作。

Procurement and logistics.

采购与物流。

Regional depots, local sourcing, equipment rental and courier networks.

区域仓库、本地采购、设备租赁和快递网络。

Please reach out to discuss trial support opportunities.

请联系以讨论试用支持机会。

About H Clinical

关于H临床

H Clinical is the leading clinical research operating platform in Latin America, working through its own in-country teams across 22 countries. It supports sponsors, contract research organizations and research sites with clinical research staffing, in-home trial support, community-based patient recruitment, and procurement logistics.

H Clinical 是拉丁美洲领先的临床研究运营平台，通过其在22个国家的本土团队开展工作。它为申办方、合同研究组织和研究机构提供临床研究人员配置、居家试验支持、基于社区的患者招募以及采购物流服务。

H Clinical empowers sponsors to reach patients that usual channels miss. The company operates the largest in-home trial, mobile site, logistics and depot network in the region..

H Clinical 助力申办方触达传统渠道难以覆盖的患者群体。该公司运营着该地区规模最大的居家临床试验、移动站点、物流及仓储网络。

About Emerald Square Ventures

关于 Emerald Square Ventures

Emerald Square Ventures

翡翠广场创投

is an operator-led investment platform that acquires and operates clinical research and life sciences businesses.

是一个由运营商主导的投资平台，收购并运营临床研究和生命科学企业。

Media Contact

媒体联系人

Media Relations

媒体关系

[email protected]